Marsh & McLennan Companies, Inc. (NYSE:MRSH – Get Free Report) Director Lloyd Yates sold 12,000 shares of the business’s stock in a transaction dated Thursday, July 23rd. The shares were sold at an average price of $175.65, for a total transaction of $2,107,800.00. Following the completion of the sale, the director owned 12,001 shares in the company, valued at approximately $2,107,975.65. This trade represents a 50.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Marsh & McLennan Companies Price Performance
Shares of MRSH opened at $192.28 on Wednesday. The company’s 50-day moving average is $171.78. The firm has a market capitalization of $91.76 billion, a PE ratio of 23.51, a PEG ratio of 2.63 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a 1-year low of $156.60 and a 1-year high of $213.80. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 1.22.
Marsh & McLennan Companies (NYSE:MRSH – Get Free Report) last issued its quarterly earnings data on Tuesday, July 21st. The financial services provider reported $2.96 EPS for the quarter, topping the consensus estimate of $2.89 by $0.07. The firm had revenue of $7.28 billion for the quarter. Marsh & McLennan Companies had a net margin of 14.24% and a return on equity of 32.67%. The business’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, sell-side analysts expect that Marsh & McLennan Companies, Inc. will post 10.42 earnings per share for the current fiscal year.
Marsh & McLennan Companies Increases Dividend
Analyst Upgrades and Downgrades
Several research firms recently issued reports on MRSH. Cantor Fitzgerald boosted their price objective on Marsh & McLennan Companies from $210.00 to $218.00 and gave the company an “overweight” rating in a report on Thursday, July 9th. Wells Fargo & Company lifted their target price on Marsh & McLennan Companies from $186.00 to $188.00 and gave the company an “equal weight” rating in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. boosted their price target on shares of Marsh & McLennan Companies from $206.00 to $212.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Weiss Ratings lowered shares of Marsh & McLennan Companies from a “hold (c)” rating to a “hold (c-)” rating in a research note on Monday, May 11th. Finally, Barclays dropped their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, eleven have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $201.94.
Institutional Inflows and Outflows
Hedge funds have recently made changes to their positions in the business. Solstein Capital LLC purchased a new position in Marsh & McLennan Companies in the fourth quarter valued at approximately $25,000. Asset Dedication LLC purchased a new position in shares of Marsh & McLennan Companies in the 1st quarter valued at $25,000. SHP Wealth Management purchased a new stake in Marsh & McLennan Companies in the fourth quarter valued at $26,000. KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at about $27,000. Finally, Golden State Wealth Management LLC acquired a new stake in shares of Marsh & McLennan Companies in the 4th quarter valued at about $27,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
Further Reading
- Five stocks we like better than Marsh & McLennan Companies
- These 3 Stocks Have Soared in 2026—Can They Keep Climbing?
- Hasbro’s Earnings Beat Shows Why This Is No Longer Just a Toy Story
- Rambus: Another AI Phoenix Ready to Rise From the Ashes of Correction
- Chips & Clips: Memory Tariffs Rewire Tech Supply Chains
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
